Trials / Active Not Recruiting
Active Not RecruitingNCT05989217
Conservative Therapies in the Treatment of Temporomandibular Disorders
Conservative Therapies in the Treatment of Temporomandibular Disorders: a Randomized Controlled Clinical Trial.
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Universidade Federal de Alfenas · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The present study was designed to evaluate different conservative therapies in patients with temporomandibular disorders. A total of 160 patients will be selected after the diagnosis of TMD according to the Diagnostic Criteria for Temporomandibular Disorder (DC/TMD), axis I. Patients will be randomly divided into five groups: OD group (n=32): treated with an occlusal device; LLLT group (n=32): treated with infrared low-level laser; ODL group (n=32): treated with OD + LLLT; LAT group (n=32): treated with laser acupuncture and ODLAT group (n=32): treated with both OD and LAT. Patients undergoing therapy with a stabilizing plate (made using the simplified technique) will be instructed to use the device every night while sleeping for four weeks. In both the LLLT and LAT groups, the protocol involved five applications: one at baseline, followed by four subsequent weekly sessions. The intensity of pain will be classified using the Visual Analog Scale (VAS). Mandible function will be assessed by maximum unassisted mouth opening. The impact of therapies on oral health will also be evaluated using the Oral Health Impact Profile (OHIP-14) instrument in a simplified form.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Occlusal Splint | Occlusion Splint |
| RADIATION | Laser Therapy | Laser Therapy |
| RADIATION | Acupuncture Laser Therapy | Acupuncture Laser Therapy |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2023-12-30
- Completion
- 2025-09-30
- First posted
- 2023-08-14
- Last updated
- 2025-07-20
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05989217. Inclusion in this directory is not an endorsement.